Affinity Asset Advisors, LLC 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Affinity Asset Advisors, LLC disclosed 95 US equity positions worth $1.7bn in its Q1 2026 13F filing. The largest position was APGE at 6.3% of the reported book, followed by XENE and ERAS.
What did Affinity Asset Advisors, LLC own in Q1 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | APGE APOGEE THERAPEUTICS INC | Healthcare | 6.3% | $108.2m | 1,284,926 | – | |
| 2 | XENE XENON PHARMACEUTICALS INC | Healthcare | 5.7% | $97.4m | 1,675,000 | – | |
| 3 | ERAS ERASCA INC | Healthcare | 5.1% | $86.6m | 5,350,000 | – | |
| 4 | INSM INSMED INC | Healthcare | 4.6% | $78.5m | 480,000 | – | |
| 5 | ROIV ROIVANT SCIENCES LTD | Healthcare | 4.5% | $77.6m | 2,800,000 | – | |
| 6 | SYRE SPYRE THERAPEUTICS INC | Healthcare | 3.8% | $64.5m | 1,279,134 | – | |
| 7 | CNTA CENTESSA PHARMACEUTICALS PLC | 3.3% | $55.6m | 1,400,000 | – | ||
| 8 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 3.2% | $54.8m | 170,000 | – | |
| 9 | ANAB ANAPTYSBIO INC | Healthcare | 3.1% | $52.1m | 940,000 | – | |
| 10 | ALKS ALKERMES PLC | Healthcare | 2.8% | $47.7m | 1,350,000 | – | |
| 11 | CYTK CYTOKINETICS INC | Healthcare | 2.7% | $46.2m | 700,483 | – | |
| 12 | ABVX ABIVAX SA | Healthcare | 2.6% | $45.1m | 405,000 | – | |
| 13 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 2.5% | $42.2m | 1,400,000 | – | |
| 14 | ACLXGBX ARCELLX INC | 2.4% | $41.7m | 362,764 | – | ||
| 15 | NUVALENT INC | 1.8% | $30.7m | 300,000 | – | ||
| 16 | 430 TERNS PHARMACEUTICALS INC | 1.7% | $29.7m | 562,631 | – | ||
| 17 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 1.7% | $29.4m | 350,000 | – | |
| 18 | LXEO LEXEO THERAPEUTICS INC | Healthcare | 1.7% | $29.0m | 5,050,211 | – | |
| 19 | COGT COGENT BIOSCIENCES INC | Healthcare | 1.7% | $28.9m | 750,000 | – | |
| 20 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 1.7% | $28.8m | 55,000 | – | |
| 21 | STRO SUTRO BIOPHARMA INC | Healthcare | 1.6% | $26.6m | 1,069,519 | – | |
| 22 | FBRX FORTE BIOSCIENCES INC | 1.5% | $26.2m | 1,011,890 | – | ||
| 23 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 1.4% | $24.5m | 499,673 | – | |
| 24 | TRVI TREVI THERAPEUTICS INC | Healthcare | 1.4% | $23.9m | 2,000,172 | – | |
| 25 | OVID OVID THERAPEUTICS INC | Healthcare | 1.4% | $23.6m | 10,636,318 | – | |
| 26 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 1.3% | $23.0m | 586,904 | – | |
| 27 | ASND ASCENDIS PHARMA A/S | Healthcare | 1.3% | $21.7m | 95,000 | – | |
| 28 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.2% | $20.3m | 750,000 | – | |
| 29 | AVTX AVALO THERAPEUTICS INC | Healthcare | 1.2% | $20.0m | 1,340,840 | – | |
| 30 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 1.1% | $18.1m | 172,125 | – | |
| 31 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 0.9% | $15.9m | 500,000 | – | |
| 32 | ZURA ZURA BIO LTD | Healthcare | 0.9% | $15.3m | 2,564,303 | – | |
| 33 | NRIX NURIX THERAPEUTICS INC | Healthcare | 0.9% | $15.0m | 967,620 | – | |
| 34 | SVRA SAVARA INC | Healthcare | 0.8% | $13.7m | 2,512,153 | – | |
| 35 | OMEROS CORP | 0.8% | $13.2m | 6,525,000 | – | ||
| 36 | CATX PERSPECTIVE THERAPEUTICS INC | 0.8% | $13.2m | 3,164,582 | – | ||
| 37 | HELIX ACQUISITION CORP III | 0.7% | $12.7m | 1,250,000 | – | ||
| 38 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 0.7% | $12.5m | 200,000 | – | |
| 39 | DMRA DAMORA THERAPEUTICS INC | Healthcare | 0.7% | $11.7m | 450,000 | – | |
| 40 | EPRX EUPRAXIA PHARMACEUTICALS INC | 0.7% | $11.5m | 1,589,005 | – | ||
| 41 | ANRO ALTO NEUROSCIENCE INC | Healthcare | 0.7% | $11.2m | 500,000 | – | |
| 42 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 0.7% | $11.1m | 150,000 | – | |
| 43 | CGEM CULLINAN THERAPEUTICS INC | Healthcare | 0.7% | $11.1m | 781,260 | – | |
| 44 | BLTE BELITE BIO INC | Healthcare | 0.6% | $10.4m | 65,000 | – | |
| 45 | WVE WAVE LIFE SCIENCES LTD | Healthcare | 0.6% | $10.2m | 1,401,727 | – | |
| 46 | VERA VERA THERAPEUTICS INC | Healthcare | 0.6% | $10.1m | 250,000 | – | |
| 47 | TYRA TYRA BIOSCIENCES INC | Healthcare | 0.6% | $9.9m | 257,512 | – | |
| 48 | RVMD REVOLUTION MEDICINES INC | Healthcare | 0.6% | $9.7m | 100,000 | – | |
| 49 | JBIO JADE BIOSCIENCES INC | Healthcare | 0.5% | $9.0m | 639,956 | – | |
| 50 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 0.5% | $8.9m | 300,000 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.